VAERS Reports U012222

VAERS 2006275

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U012222

schwer

Staat: CA
Alter: 11,0
Geschlecht: F
Eingang: 05.01.2022
Impfdatum: 05.01.2022
Beginn: 05.01.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: SC / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Fear Haemoglobin normal Nausea Pallor Protein urine present Syncope

Symptomtext

The patient was sitting in the chair per the mother when fainted. No head trauma. Went to the patient's room was awake with a pale face, very scared, & nauseous. Checked blood pressure 124/56mmHg, pulse 62 bpm, oxygen saturation 100%. She ate crackers and drank coca-cola (soda). Watched for 15 minutes. The patient left and was advised to call EMS if any loss of consciousness or repeated episode or new symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: Hemoglobin check before episode: 13.1 Urine check before episode: trace of protein and ordered to repeat early morning urine Blood Pressure: 124/56 mmHg Pulse: 62 bpm Oxygen saturation:100% at room temperature
Aktuelle Erkrankungen: NONE
Vorgeschichte: NONE
Andere Medikamente: NONE
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1913081

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U012222

schwer

Staat: NM
Alter: 9,0
Geschlecht: M
Eingang: 01.12.2021
Impfdatum: 01.12.2021
Beginn: 01.12.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SC / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Head injury Loss of consciousness Syncope Tremor

Symptomtext

A few minutes after administration of Varivax and Havrix, pt had a case of vasovagel syncope. Pt was standing and fell forward, striking his head upon the ground. Pt has an LoC lasting approximately 15 seconds. Pt regained consciousness and was instructed to stay laying down. Pt was evaluated by the clinic medical director, and was sat up approximately 5 minutes after the initial event. 30 seconds after sitting up pt began to shake and had a second LoC that lasted approximately 5 seconds. Full recovery time took approximately 45 minutes.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2648601

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U012222

mild

Staat: CA
Alter: -
Geschlecht: F
Eingang: 22.06.2023
Impfdatum: 26.04.2023
Beginn: 01.04.2023
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Pruritus Swelling face

Symptomtext

The patient received an expired dose of VARIVAX on 4/26/2023.; Itching; Facial Swelling; This spontaneous report was received from a licensed vocational nurse concerning a female patient of unknown age. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 26-APR-2023, the patient was vaccinated with an expired dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot #U012222, expiration date: 16-APR-2023, administered as prophylaxis (strength, and route of administration were not provided) (Expired product administered). In addition, on the same day (26-APR-2023), she also received Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) injection as prophylaxis (dose, route of administration, lot#, and expired date were not provided), meningococcal vaccine a/c/y/w conj (tet tox) (MENQUADFI), hepatitis b vaccine rhbsag (yeast) (ENGERIX-B), hepatitis a vaccine inact (HAVRIX) (doses, formulation, routes of administration, lot#, expired date, and indication were not provided). The reporter informed that all of the vaccines administered were the second dose in their respective series except hepatitis a vaccine inact (HAVRIX). On an unspecified day in April 2023, the patient experienced itching (pruritus) and facial swelling (swelling face). Therefore, her patients parent took her to the emergency department on 27-APR-2023 (approximately 24 hours after vaccination with multiple vaccines to include varicella virus vaccine live (oka/merck) [VARIVAX]) and it was suggested having the patient allergy tested. It was reported that the patient was administered a dose of an antihistamine and was subsequently sent home from the emergency department and was not admitted to the hospital. It was also stated that a Varicella Zoster Virus (VZVIP) packet being sent via email since the HCP was not available at that moment and would be back until 26-MAY-2023. No additional information was reported. The outcome of the events was not provided. The action taken and causal relationship between the events and the suspect vaccines were not reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pruritus
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2311768

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U012222

mild

Staat: WA
Alter: 23,0
Geschlecht: F
Eingang: 07.06.2022
Impfdatum: 29.04.2022
Beginn: 30.04.2022
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: SC / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injection site erythema Injection site exfoliation Injection site pruritus Injection site swelling

Symptomtext

started day after injection as itching at the injection site, progressed in the following days to small area of redness with itching at injection site, and at 5.5 weeks since injection, injection site is red, raised, flaky, itchy, BSA=half a palm's worth at site of injection on upper left arm. Pt has been treating injection site with moisturizer, otherwise no other treatments.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site erythema
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: endometriosis, unspecified psychiatric conditions
Andere Medikamente: lithium, lamotrigine, fluoxetine, combo birth control
Allergien: grass (rash, itching)
Vorherige Impfungen: -

VAERS 1984863

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U012222

mild

Staat: CA
Alter: 1,0
Geschlecht: M
Eingang: 28.12.2021
Impfdatum: 13.12.2021
Beginn: 13.12.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SC / RL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Injection site erythema Pruritus Pyrexia Rash Rash macular

Symptomtext

Mom reports that patient had fever of 101-102 on 12/21/21-12/23/21. Mom reports that the rash popped up on his trunk around 12/22/21. Mom reports that he was scratching at it. She has pictures on her phone. It appears to be a confluent, pink macular rash on trunk and face. But patient does appear to be scratching at it on the pictures and video. Mom reports that he also had a bright red line on his right thigh where he got his Varicella vaccine on 12/13/21.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site erythema
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: Cough from 11/14/2021 until 11/29/2021
Vorgeschichte: None
Andere Medikamente: N/A
Allergien: No known allergies.
Vorherige Impfungen: -

VAERS 2636150

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U012222

gering

Staat: CA
Alter: -
Geschlecht: U
Eingang: 02.06.2023
Impfdatum: 26.04.2023
Beginn: 26.04.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

Did not experience any other adverse event; the patient received an expired dose of VARIVAX on 4/26/2023.; This spontaneous report was received from a licensed vocational nurse concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 26-APR-2023, the patient was vaccinated with an expired dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot #U012222, expiration date: 16-APR-2023, administered as prophylaxis (strength, and route of administration were not provided) (Expired product administered). The patient did no experience any other adverse events.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2637889

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge u012222

gering

Staat: CA
Alter: -
Geschlecht: U
Eingang: 29.05.2023
Impfdatum: 26.04.2023
Beginn: 26.04.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

the patient did not experience any other adverse event; The caller said the patient received an expired dose of VARIVAX on 4/26/2023; This spontaneous report was received from nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 26-APR-2023, the patient was vaccinated with expired dose of varicella virus vaccine live (oka/merck) (VARIVAX) injection, 1 dose, lot #u012222, expiration date: 16-APR-2023, administered for prophylaxis (strength, and route of administration were not provided) (expired product administered). Confirmed with caller the patient did not experience any other adverse event.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2636180

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U012222

gering

Staat: CA
Alter: -
Geschlecht: U
Eingang: 29.05.2023
Impfdatum: 26.04.2023
Beginn: 26.04.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

the patient did not experience any other adverse event.; Caller reported an AE for VARIVAX. The caller said the patient received an expired dose of VARIVAX on 4/26/2023.; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant medications, and drug reactions or allergies were not provided. On 26-APR-2023, the patient was vaccinated with an expired dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 1 dose (valid lot number U012222 [expiration date 16-APR-2023]) (dose, frequency, vaccination scheme, route of administration, and anatomical location, lot number and expiration date were not provided) administered for prophylaxis (Expired product administered). The patient did not experience any other adverse event.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2636180

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge u012222

gering

Staat: CA
Alter: -
Geschlecht: U
Eingang: 29.05.2023
Impfdatum: 26.04.2023
Beginn: 26.04.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

the patient did not experience any other adverse event.; Caller reported an AE for VARIVAX. The caller said the patient received an expired dose of VARIVAX on 4/26/2023.; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant medications, and drug reactions or allergies were not provided. On 26-APR-2023, the patient was vaccinated with an expired dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 1 dose (valid lot number U012222 [expiration date 16-APR-2023]) (dose, frequency, vaccination scheme, route of administration, and anatomical location, lot number and expiration date were not provided) administered for prophylaxis (Expired product administered). The patient did not experience any other adverse event.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2636146

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U012222

gering

Staat: CA
Alter: 17,0
Geschlecht: F
Eingang: 24.05.2023
Impfdatum: 26.04.2023
Beginn: 26.04.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Varicella Vaccine was expired 4/16/23 and administered 4/26/23. Per patient no adverse reaction was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2626846

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U012222

gering

Staat: OR
Alter: 6,0
Geschlecht: F
Eingang: 04.05.2023
Impfdatum: 18.04.2023
Beginn: 18.04.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No additional AEs; expired lot of VARIVAX was administered to patient; This spontaneous report was received from a Registered Nurse (RN) regarding a 6-year-old-female patient. Her medical history, historical drugs, known allergies, concurrent conditions, and concomitant therapies were not reported. On 18-APR-2023, the patient was vaccinated with an expired dose of varicella virus vaccine live (Oka/Merck) (VARIVAX), 0.5 milliliter once, lot # U012222 and expiry date: 16-APR-2023 (route of administration was not provided) for prophylaxis. No further information provided, no additional adverse events were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2618702

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U012222

gering

Staat: OR
Alter: -
Geschlecht: U
Eingang: 21.04.2023
Impfdatum: 17.04.2023
Beginn: 17.04.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No additional AEs or PQC reported.; Caller reported expired dose of VARIVAX administered.; This spontaneous report has been received from a pharmacist, concerning a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, drugs reactions or allergies and concomitant medications were not provided. On 17-APR-2023, the patient was vaccinated with one expired dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous Injection, 0.5 milliliter (ml) administered intramuscularly (valid lot number U012222 with an expiration date on 16-APR-2023) (dose number, vaccination scheme, frequency and anatomical injection site were not provided) administered concomitantly with sterile diluent (dose, frequency, lot number and expiration date were not provided) for prophylaxis (expired product administered). No additional (adverse events) reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: STERILE DILUENT
Allergien: -
Vorherige Impfungen: -

VAERS 2618701

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U012222

gering

Staat: CA
Alter: -
Geschlecht: U
Eingang: 21.04.2023
Impfdatum: 17.04.2023
Beginn: 17.04.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No additional AEs/no PQCs.; HCP reported that an expired dose of VARIVAX was administered to a patient on 4/17/23.; This spontaneous report has been received from a nurse, concerning a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, drugs reactions or allergies and concomitant medications were not provided. On 17-APR-2023, the patient was vaccinated with one expired dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous Injection (valid lot number U012222 with an expiration date on 16-APR-2023) (dose, dose number, vaccination scheme, frequency and anatomical injection site were not provided) for prophylaxis (expired product administered). No additional (adverse events) reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2388123

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U012222

gering

Staat: NM
Alter: 44,0
Geschlecht: F
Eingang: 25.07.2022
Impfdatum: 25.05.2022
Beginn: 25.05.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: SC / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

No adverse event Wrong product administered

Symptomtext

Patient scheduled for MMR but received Varicella vaccine instead. Error caught and MMR documented as administered on 5/25/22 as well. No adverse effects documented from administration of Varicella vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: HTN, OSA, GERD, hypothyroid, anxiety, prediabetes
Andere Medikamente: Buspar, chlorthalidone, citalopram, clonidine, ibuprofen, norgestimate-ethinyl estradiol, Omega 3, omeprazole, potassium chloride, NP Thyroid
Allergien: penicillin, Wellbutrin
Vorherige Impfungen: -

VAERS 1770259

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U012222

gering

Staat: NV
Alter: -
Geschlecht: M
Eingang: 08.10.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

one dose of V ARlV AX was administered to a patient while it was undergoing a temperature excursion.; no adverse event; This spontaneous report as received from a medical assistant and refers to a male patient of unknown age. The patient's concurrent conditions, medical history, and concomitant medications were not reported. On an unknown date, the patient was vaccinated with a dose of varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 milliliter (route of administration and anatomical localtion were not reported) (lot # U012222 has been verified to be a valid lot number, expiration date reported as 16-APR-2023) for prophylaxis. The vaccine was administered while undergoing a temperature excursion (product storage error). The patient did not report any adverse events from receiving the varicella virus vaccine live (oka/merck) (VARIVAX) dose.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -